La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Mainz Biomed a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Mainz Biomed..

Mainz Biomed (NASDAQ:MYNZ) Azioni, Catena delle Opzioni

Mainz Biomed

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Mainz Biomed NV

Citigroup analyst Anthony Pettinari maintains Sealed Air (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) with a Buy and raises the price target from $33 to $37.

News

Price Target

Analyst Ratings

Citigroup Maintains Buy on Sealed Air, Raises Price Target to $37

Citigroup analyst Anthony Pettinari maintains Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) with a Neutral and raises the price target from $177 to $185.

Citigroup Maintains Neutral on Avery Dennison, Raises Price Target to $185

Citigroup analyst Paul Lejuez maintains Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) with a Neutral and raises the price target from $19 to $22.

LEVI

Citigroup Maintains Neutral on Levi Strauss, Raises Price Target to $22

Citigroup analyst Jason Bazinet maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $100 to $123.

RBLX

Citigroup Maintains Buy on Roblox, Raises Price Target to $123

Legends of the game of tennis are speaking out in criticism of billionaire hedge fund manager Bill Ackman after he recently took part in a <a href="https://www.benzinga.com/news/sports/25/07/46253533/bill-ackman-swaps-wall-street-for-tennis-court-and-he-is-playing-to-win-you-never-know" target="_blank" rel="noopener">professional tennis match.</a>
Here's what they had to say and what Ackman is saying about his loss.
What Happened: Social media was full <a href="https://www.benzinga.com/news/sports/25/07/46335848/bill-ackman-draws-near-sell-out-crowd-but-also-social-media-scorn-after-lopsided-loss-in-newport-tennis-doubles-debut">of brutal criticism </a>for Ackman and tennis partner Jack Sock's recent 6-1, 7-5 loss in a doubles match to Omar Jasika and Bernard Tomic.
The match also saw criticism from tennis legends Andy Roddick and Martina Navratilova.
Roddick called the match a disaster, as <a href="https://nypost.com/2025/07/10/business/tennis-legends-andy-roddick-martina-navratilova-slam-bill-ackman/">reported </a>by the New York Post.
"The biggest joke I've ever watched in professional tennis," Roddick, a former U.S. Open champion, said.
Navratilova, who is one of the winningest women's tennis players of all time, took exception to the way Ackman got a spot in the ATP Hall of Fame Open.
"Apparently you can buy yourself a wild card. Oh to have the confidence…" Navratilova <a href="https://x.com/Martina/status/1943250768448098741">tweeted</a>.
The comments from Navratilova, who won more than 50 Grand Slam tennis events in both singles and doubles, come as Ackman got into the tournament through a "wildcard" system. Ackman did not have to qualify from rankings or from competing in lower-level matches first.
Tennis journalist Jon Wertheim has highlighted the fact that Ackman is a financial supporter of the Professional Tennis Players Association. Most of the journalist's criticism stems from Ackman being allowed in an officially sanctioned event that offered prize money and ATP ranking points instead of being an amateur event.
Read Also: <a href="https://www.benzinga.com/news/management/25/05/45456642/bill-ackman-loads-up-on-uber-dumps-nike-in-major-q1-portfolio-rebalance">Bill Ackman Loads Up On Uber In Major Q1 Portfolio Rebalance</a>
What Ackman Said: Ackman is fighting back against the criticism of his tennis match.
"The press on my professional debut has been brutal, and indeed, it was not my best showing," Ackman <a href="https://x.com/BillAckman/status/1943474142193553535">said</a>.
Ackman acknowledged the first set was a blowout with the 6-1 score, but said that a number of things, like missed break points, could have changed the outcome of the second set and forced a third tiebreaker set.
"All in all a great experience for which I am eternally grateful."
In an earlier social media <a href="https://x.com/BillAckman/status/1943289893859282944">post</a>, Ackman said the tennis match was a "very humbling experience" that gave him more respect for the pros.
Ackman admitted he had some "stage fright" in his match.
"I can speak in front of an audience of a thousand people or in a TV studio on a broad range of topics without any preparation and without a twinge of fear, but yesterday I had my first real experience with stage fright."
Ackman has not said whether he will be competing in more tennis matches in the future.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45730063/new-etfs-let-investors-mirror-buffett-ackman-burrys-top-stock-trades">New ETFs Let Investors Mirror Buffett, Ackman, Burry&#8217;s Top Stock Trades</a></li>
</ul>
Photo: PeopleImages.com &#8211; Yuri A/Shutterstock

Sports

General

Bill Ackman Jeered For Tennis Match By Former Champions: 'The Biggest Joke I've Ever Watched'

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), the original memecoin, is surging Friday afternoon, capturing significant gains as a wave of speculative enthusiasm washes over the crypto market for the session.
What To Know: Friday&#8217;s jump comes in <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46363070/bitcoin-sets-all-time-high-at-118909-ethereum-xrp-surge-8-each">direct sympathy</a> with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), which rocketed to a new all-time high of over $118,000. The surge by the world&#8217;s leading cryptocurrency is creating a powerful ripple effect, reigniting interest in high-beta assets like Dogecoin.
Bitcoin&#8217;s record-breaking climb is largely attributed to sustained institutional buying, particularly through U.S.-listed spot Bitcoin ETFs, which have seen billions in net inflows. This strong institutional interest signals <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46317095/bitcoin-miners-rake-in-55k-daily-despite-heat-driven-hashrate-dip-heres-their-secret">growing confidence</a> in the cryptocurrency sector, creating a risk-on environment that benefits more speculative assets.
Historically, when Bitcoin breaks new ground, a <a href="https://www.benzinga.com/markets/equities/25/07/46359853/mara-stock-spikes-in-after-hours-trading-as-bitcoin-hits-new-all-time-high">wave of optimism</a> and retail investor interest tends to flow into the altcoin market. Dogecoin, with its massive brand recognition and strong community, often becomes a primary beneficiary of this trend. Investors, buoyed by Bitcoin&#8217;s performance, frequently look to memecoins for high-risk, high-reward opportunities.
Read Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/07/46372447/the-bitcoin-etf-boom-is-here-but-is-it-built-to-last">The Bitcoin ETF Boom Is Here — But Is It Built To Last?</a>
This phenomenon of market-wide euphoria, led by Bitcoin, is a <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46363070/bitcoin-sets-all-time-high-at-118909-ethereum-xrp-surge-8-each">primary driver</a> of Dogecoin&#8217;s sharp price increase Friday afternoon, as a rising tide in the crypto market often lifts top altcoins.
What Else: Dogecoin is a decentralized, open-source cryptocurrency that <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">originated</a> as a lighthearted joke in 2013. Created by software engineers Billy Markus and Jackson Palmer, the digital coin features the face of the &#8220;Doge&#8221; meme&#8217;s Shiba Inu dog as its logo. 
Despite its satirical beginnings, Dogecoin quickly developed a vibrant and active community, gaining traction as a currency for tipping online content creators and for small, fast transactions. Technically, it is based on the same underlying proof-of-work technology as Litecoin. 
Unlike Bitcoin, which has a finite supply, Dogecoin is inflationary, with a large and uncapped circulating supply, a feature intended to encourage its use as a currency rather than a store of value. Over the years, it has become one of the most well-known cryptocurrencies, often driven by social media trends and endorsements from high-profile personalities.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Dogecoin is trading higher by 5.7% to $0.2090 Friday afternoon.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46364862/bitcoin-ethereum-xrp-dogecoin-go-parabolic-as-money-making-season-gains-steam">Bitcoin, Ethereum, XRP, Dogecoin Go Parabolic As &#8216;Money-Making Season&#8217; Gains Steam</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$DOGE

Dogecoin (DOGE) Soars As Bitcoin Rally Ignites Memecoin Frenzy

Citigroup analyst Asiya Merchant maintains Logitech International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) with a Neutral and raises the price target from $85 to $100.

LOGI

Citigroup Maintains Neutral on Logitech International, Raises Price Target to $100

M&amp;T Bank Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/MTB/earnings">opening bell on Wednesday, July 16.</a>
Analysts expect the Buffalo, New York-based company to report quarterly earnings at $4.00 per share, up from $3.79 per share in the year-ago period. M&amp;T Bank projects to report quarterly revenue at $2.39 billion, compared to $2.3 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 5, M&amp;T Bank and the Galesi Group launched a major partnership that will expand their collaborative efforts to accelerate and sustain the revitalization of Schenectady&#8217;s Mohawk Harbor.
M&amp;T Bank shares rose 1.8% to close at $204.05 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/mtb/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Citigroup analyst Keith Horowitz maintained a Neutral rating and raised the price target from $200 to $212 on July 2, 2025. This analyst has an accuracy rate of 79%.</li>
<li>Morgan Stanley analyst Manan Gosalia maintained an Overweight rating and boosted the price target from $206 to $215 on June 20, 2025. This analyst has an accuracy rate of 76%.</li>
<li>RBC Capital analyst Gerard Cassidy reiterated an Outperform rating with a price target of $200 on May 19, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Truist Securities analyst Brian Foran maintained a Buy rating and cut the price target from $225 to $200 on April 15, 2025. This analyst has an accuracy rate of 76%.</li>
<li>RBC Capital analyst Brad Erickson maintained an Outperform rating and cut the price target from $208 to $200 on April 15, 2025. This analyst has an accuracy rate of 74%.</li>
</ul>
Considering buying MTB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/MTB/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10210234/image-127-1024x584.png" alt="" class="wp-image-980919" style="width:629px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10210234/image-127-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10210234/image-127-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10210234/image-127-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/10210234/image-127.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46341009/how-to-earn-500-a-month-from-jpmorgan-stock-ahead-of-q2-earnings">How To Earn $500 A Month From JPMorgan Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

Earnings

Trading Ideas

M&T Bank Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones index dipping more than 250 points on Friday.
The Dow traded down 0.60% to 44,382.58 while the NASDAQ rose 0.06% to 20,643.06. The S&amp;P 500 also fell, dropping, 0.23% to 6,266.23.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46318208/top-2-tech-stocks-that-may-plunge-this-month">Top 2 Tech Stocks That May Plunge This Month</a>
Leading and Lagging Sectors Energy shares jumped by 0.6% on Friday.
In trading on Friday, health care stocks dipped by 1.2%.
Top Headline
WD-40 Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) posted better-than-expected earnings for its third quarter, while sales missed estimates.
The company raised its FY2025 EPS guidance, but narrowed its sales forecast.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>MiNK Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) shares shot up 526% to $48.40 after the company announced a publication in Oncogene.</li>
<li>Shares of Ruanyun Edai Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) got a boost, surging 19% to $18.37. Ruanyun Edai Technology signed a strategic partnership with Confucius Institute at Prince Sultan University to scale HanLink across Saudi Arabia.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) shares were also up, gaining 98% to $2.4350 after the company announced it has made advancements regarding its business combination with One BlockchAIn.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Milestone Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIST#NASDAQ">MIST</a>) shares dropped 41% to $1.5050 after the company announced a public offering.</li>
<li>Shares of Federal Agricultural Mortgage Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGM#NYSE">AGM</a>) were down 11% to $175.20. Farmer Mac announced the departure of Chief Financial Officer, Aparna Ramesh.</li>
<li>TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) was down, falling 10% to $112.93.</li>
</ul>
Commodities In commodity news, oil traded up 2.6% to $68.28 while gold traded up 1.5% at $3,375.80.
Silver traded up 4.1% to $38.830 on Friday, while copper fell 0.9% to $5.5425.
Euro zone
European shares were lower today. The eurozone's STOXX 600 dipped 1.07%, while Spain's IBEX 35 Index fell 0.99%. London's FTSE 100 fell 0.47%, Germany's DAX 40 slipped 0.81% and France's CAC 40 declined 0.94% during the session.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei falling 0.19%, Hong Kong's Hang Seng gaining 0.46%, China's Shanghai Composite gaining 0.01% and India's BSE Sensex falling 0.83%.
Economics
The Baker Hughes oil rig count report for the latest week will be released today.
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46361010/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts-2">Johnson &amp; Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

INKT

MIST

RYET

TMDX

WDFC

Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge

Citigroup analyst Asiya Merchant maintains Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) with a Buy and raises the price target from $62 to $78.

Citigroup Maintains Buy on Western Digital, Raises Price Target to $78

Expedia Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) is drawing fresh optimism from Wall Street amid signs of a <a href="https://www.benzinga.com/analyst-stock-ratings">rebound in U.S. travel demand. </a> Bank of America Securities (BofA) analyst Justin Post reiterated the Buy rating on Expedia Group, <a href="https://www.benzinga.com/quote/EXPE/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price forecast of $211.</a>
Post maintains a positive stance on Expedia, noting that a mild recovery in U.S. bookings during the summer and shoulder season could catalyze the stock, which is heavily tied to the domestic travel market.
The analyst sees fewer downside risks to estimates, thanks to stabilizing trends since April, and points to multiple key tailwinds that could aid Expedia.
Also Read: <a target="_blank" href="https://www.benzinga.com/content/46072500/3-travel-stocks-to-play-the-consumer-sentiment-rebound" rel="noreferrer noopener">3 Travel Stocks to Play the Consumer Sentiment Rebound</a>
These include continued growth in its B2B and advertising segments, aided by new airline partnerships with Southwest Airlines Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) and Ryanair Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>).
Post expects EBITDA to grow 7% in 2025, based on conservative 2% growth from the B2C segment, which is reasonable given the company's flat U.S. and 33% international exposure. 
He also highlights Expedia's strong free cash flow profile and buyback potential, estimating the company could repurchase some 10% of its shares over the next year, excluding dividends.
This, combined with easier year-over-year comparisons in 2026, could help improve investor sentiment.
The stock, which has lagged peers year-to-date, is currently trading at 5.8x estimated 2026 EBITDA and 9x expected 2026 FCF—valuations that Post believes remain attractive.
U.S. air travel data continues to show year-over-year declines, with June airline spending down 10.9% and lodging spending down 3.5%, according to Bank of America card data.
While these figures mark a further deceleration from May, Post believes the stability in recent trends reduces the risk of further estimate cuts.
Price Action: EXPE shares are trading higher by 0.88% to $184.60&nbsp;at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46368613/3-stocks-to-sell-now-that-trumps-big-beautiful-bill-is-law" target="_blank" rel="noreferrer noopener">3 Stocks To Sell Now That Trump's Big Beautiful Bill Is La</a></li>
</ul>
Photo: Shutterstock

EXPE

RYAAY

Expedia Gears Up For Takeoff As Travel Bookings Bounce Back

WIIM

AFRM

PYPL

SEZL

Shares of several payments and fintech stocks are trading lower following a comment from JP Morgan that fintech companies will have to pay up for customer data.

Citigroup analyst Asiya Merchant maintains Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Buy and raises the price target from $140 to $170.

Citigroup Maintains Buy on Seagate Tech Hldgs, Raises Price Target to $170

Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) stock has significantly <a href="https://www.benzinga.com/topic/cybersecurity">outperformed</a> the market, surging 71% year-to-date, fueled by a robust 73% gain in its most recent quarter. In contrast, the NYSE Composite Index, which includes Cloudflare, rose only 8% and 13% during the same respective periods.
Cloudflare is a cybersecurity company that delivers internet infrastructure services that improve website and app speed, security, and reliability.
The company operates as a Content Delivery Network (CDN) by using its global server network to cache and deliver website content near end users, boosting site speed and performance.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43570917/cloudflares-ai-expansion-and-enterprise-growth-set-the-stage-for-big-gains-analysts" rel="noreferrer noopener">Buy Cloudflare Or Sell? Analysts Vary Over Sales Acceleration And Business Momentum</a>
The global CDN market is expected <a target="_blank" href="https://www.precedenceresearch.com/content-delivery-network-market" rel="noreferrer noopener">to grow from</a> $27.59 billion in 2024 to over $144.91 billion by 2034, expanding at a compound annual growth rate (CAGR) of 18.04% between 2025 and 2034.
Companies like Cloudflare have the potential to gain from the&nbsp;rapidly expanding CDN space as consumers increasingly turn to streaming video and audio content. However, its competitors include Big Tech giants like Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web Services.
<h2 class="wp-block-heading">Recent Quarter Results</h2>
On May 8, Cloudflare reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45303427/cloudflare-stock-rises-on-q1-earnings-after-landing-largest-contract-in-company-history-innovation-wins-in-a-constantly-changing-world" rel="noreferrer noopener">first-quarter revenue</a> of $479.09 million, up 27% on a year-over-year basis, topping analyst consensus estimates&nbsp;of $469.28 million backed by over $100 million deal driven by its Workers developer platform, and the longest-term SASE contract to date.
Cloudflare expects second-quarter revenue of $500 million-$501 million versus estimates of $500.34 million. Cloudflare also affirmed its full-year 2025 guidance, including revenue of $2.09 billion-$2.094 billion versus estimates of $2.09 billion.
<h2 class="wp-block-heading">Analyst Take On Cloudflare</h2>
Thirty-three analysts set a <a href="https://www.benzinga.com/quote/NET/analyst-ratings" target="_blank" rel="noreferrer noopener">consensus price target</a> of $141.56 for Cloudflare. Morgan Stanley issued the highest target at $225 on July 11, 2025. Based on the latest ratings from Morgan Stanley, KeyBanc, and Oppenheimer, who collectively averaged a $211.67 target, Cloudflare shares have an implied 15.09% upside.
Needham analyst Mike Cikos <a target="_blank" href="https://www.benzinga.com/25/05/45324074/cloudflares-big-deal-and-strong-sales-drive-stock-price-growth-says-analyst" rel="noreferrer noopener">expressed optimism over</a> the stock after its quarterly results, citing its record-breaking $130 million, five-year Pool-of-Funds agreement, beating out AWS. The analyst highlighted Cloudflare&#8217;s business model shift from network investment and a freemium approach to deeper service functionality and targeting large enterprise adoption. The analyst said its technology is well-suited to address critical problems and support emerging trends like Cloud Direct, Zero Trust, digital transformation, multi-cloud, and Edge Compute.
On March 26, Goldman Sachs analyst Gabriela Borges <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44503722/cloudflares-developer-and-ai-tools-fuel-long-term-growth-goldman-sachs-analyst-says" rel="noreferrer noopener">maintained a Buy</a> rating on Cloudflare with a $161 price forecast, citing strong AI inference potential. Borges expects Cloudflare&#8217;s Act III products to grow from $80 million ARR in 2024 to $1.3 billion by 2030, supported by rising capex and GPU investment. She believes Cloudflare&#8217;s early-stage product cycle and tech advantages will help it capture a significant share of the AI-driven profit pool.
On March 25, Bank of America Securities analyst Madeline Brooks upgraded Cloudflare to Buy and <a target="_blank" href="https://www.benzinga.com/25/03/44480078/cloudflares-ai-push-and-security-surge-lead-to-major-upgrade-analyst-projects-30-growth" rel="noreferrer noopener">raised the price forecast</a> to $160 from $60, citing strong AI-as-a-Service and security growth.
Brooks believes Cloudflare could emerge as a leading AI-as-a-Service provider, as enterprises increasingly favor this model for adopting AI tools. She notes that Cloudflare is gaining momentum in network security, especially in SASE, as businesses shift toward software-based security solutions.
She expects this strength in AI and security to fuel a 30% compound annual growth rate over the next three years, up from her 25% estimate. Brooks adds that enterprises choose Cloudflare over major hyperscalers like AWS, Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), and Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure due to its ease of use, scalability, and better resource efficiency.
Brooks sees Cloudflare meeting full-year revenue guidance but warns it must execute flawlessly to hit its ambitious $5 billion revenue target by 2028.
On June 11, Cathie Wood&#8217;s&nbsp;Ark Invest&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/45897032/cathie-woods-ark-invest-continues-to-offload-palantir-loads-up-on-beam-therapeutics-gitlab" rel="noreferrer noopener">made significant trades</a>, with Cloudflare being a prominent stock. Ark Invest sold 5,193 Cloudflare shares.
<h2 class="wp-block-heading">Recent Expansion Initiatives By Cloudflare</h2>
On June 13, Cloudflare <a target="_blank" href="https://www.benzinga.com/markets/offerings/25/06/45922498/cloudflare-raises-1-75-billion-in-note-offering-eyes-growth-and-strategic-moves" rel="noreferrer noopener">raised $1.75 billion</a> by pricing convertible notes due in 2030, generating $1.72 billion in net proceeds and including an option to increase the offering by $250 million.
The company set a 45% conversion premium and plans to use the proceeds for capped call transactions and general corporate purposes.
Price Action: NET stock is trading higher by 1.47% to $184.60 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/upgrades/25/07/46373610/amc-stock-just-got-upgrade-could-premium-screens-box-office-momentum-signal-a-comeback" target="_blank" rel="noreferrer noopener">AMC Stock Just Got Upgrade — Could Premium Screens, Box Office Momentum Signal A Comeback?</a></li>
</ul>
Photo via Shutterstock

Movers

Tech

AMZN

MSFT

ORCL

Cloudflare Soars 71% In 2025, Crushing Market Performance

Citigroup analyst Asiya Merchant maintains CDW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDW#NASDAQ">CDW</a>) with a Neutral and raises the price target from $180 to $200.

Citigroup Maintains Neutral on CDW, Raises Price Target to $200

Citigroup analyst Asiya Merchant maintains Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) with a Buy and raises the price target from $100 to $115.

Citigroup Maintains Buy on Amphenol, Raises Price Target to $115

<a href="https://www.politico.eu/article/victory-eu-donald-trump-meta-tax-digital/" title="https://www.politico.eu/article/victory-eu-donald-trump-meta-tax-digital/">https://www.politico.eu/article/victory-eu-donald-trump-meta-tax-digital/</a>

Macro Economic Events

Politics

Global

Economics

AAPL

'Victory For Trump As EU Backs Down On Digital Taxes In Next Budget; The European Commission Has Dropped Plans To Levy A Tax On Digital Companies' - Politico

Nike shares are trading lower. The company announced it will replace its Converse CEO amid its sales slump.

Citigroup analyst Asiya Merchant maintains Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Neutral and raises the price target from $37 to $52.

SMCI

Citigroup Maintains Neutral on Super Micro Computer, Raises Price Target to $52

CVM stock has given up its prior gain. CEL-SCI shares were trading higher after the company announced it signed a partnership with a Saudi Arabian pharma and healthcare company.

Health Care

Press Releases

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Financing

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

MYNZ

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

AIM ImmunoTech

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Aprea Therapeutics

Aptevo Therapeutics

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Genprex

GT Biopharma

HCW Biologics

Immuron Limited - American Depositary Shares

Immuron

IN8bio

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Moleculin Biotech

PharmaCyte Biotech

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sunshine Biopharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Turnstone Biologics

Maxim Group

JonesTrading

Screenshot 2025-04-15 at 7.03.21 PM

Biotech

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Screenshot 2025-04-02 at 9.29.30 PM

Mainz BioMed&#39;s Trial To Bring Critical Early Cancer Detection One Step Closer

Screenshot 2024-12-19 at 7.13.05 PM

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Screenshot 2024-11-21 at 6.41.48 PM

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

Screenshot 2024-11-12 at 8.43.58 PM

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

Comments

Mainz Biomed

Mainz Biomed (MYNZ) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO